Intorio Corp. Reports Zero Revenue and Increased Losses in Latest 10-Q Filing

Intorio Corp. reported significant financial challenges in its latest 10-Q filing for the period ending November 30, 2024. The company generated no revenue during the three months ended November 30, 2024, a decline from $2,000 in the same period of the previous year. For the nine months ending November 30, 2024, revenues also fell to zero, down from $4,100 in the prior year. The company recorded a net loss of $14,293 for the quarter, compared to a loss of $2,425 in the same quarter of 2023. Cumulatively, the net loss for the nine-month period reached $29,155, up from $15,878 in the previous year.

The financial position of Intorio Corp. has deteriorated, with total assets decreasing to $48,935 as of November 30, 2024, from $1,918 as of February 29, 2024. Current liabilities increased to $76,172, up from $54,161 in the previous fiscal period. The company’s accumulated deficit has also widened to $106,298, compared to $77,143 at the end of the prior period. The increase in operating expenses, particularly in professional fees and consulting services, contributed to the higher losses, with total operating expenses for the nine months reaching $28,158, compared to $19,978 in the previous year.

Strategically, Intorio Corp. underwent a significant leadership change in May 2024, when Dr. Han-Wen Ou was appointed as the new CEO following the sale of a majority stake to six accredited investors. This transition is part of a broader rebranding effort, as the company plans to operate under the name Redox International Group. The company is also focusing on expanding its functional medicine services, leveraging its existing website and operational capabilities in this sector.

Operationally, the company has not reported any customer counts or user statistics, indicating a lack of engagement metrics during the reporting period. The company’s employee headcount remains low, with only one employee aside from the executive team. Intorio Corp. has not made any significant geographic expansions or product launches, which may have contributed to its stagnant revenue performance.

Looking ahead, Intorio Corp. acknowledges the need for additional capital to sustain its operations and meet long-term requirements. Management plans to seek funding through equity or debt financing, although there is no assurance that such funding will be available on favorable terms. The company’s ability to continue as a going concern is in question, as it has yet to establish a reliable source of revenue to cover its operating costs. The management's forward-looking statements emphasize the necessity of raising funds in the next twelve months to support ongoing operations and potential growth initiatives.